In this discussion, hosted by John Malanca from the Association of Cannabinoid Specialists, Dr. Jordan Tishler explores the complexities of hemp regulation and the medical implications of cannabinoid use.
They delve into the historical context of hemp and cannabis as medicines, the legal parameters set by the 2018 Farm Bill, and the potential risks associated with the lack of testing and regulation in the hemp market.
Dr. Tishler emphasizes the importance of the 'entourage effect' and the need for multiple cannabinoids and terpenes, rather than isolated compounds, for effective medical treatment. They caution against the purchase of hemp products, which often lack safety testing, and recommend sourcing products from state-regulated dispensaries.
The conversation also covers the potential health risks of high THC usage and the critical role of medical professionals in guiding patient use of cannabis products.
The importance of clinician involvement in ensuring safe and effective cannabinoid therapy is underscored. The dialogue concludes with advice to avoid unregulated hemp products and to seek guidance from qualified cannabinoid specialists.